Sagen omfattede hverken øvrige dele af produktresuméet eller øvrige godkendte indikationer for bicalutamid 150 mg.
Other aspects of the SPC and the other indication for bicalutamide 150 mg, which is approved in some EU member states, were not within the scope of the referral.